��������

Vaibhav Bhatia is a prominent figure in the biotechnology sector, currently serving as the Chief Executive Officer and Founder of Lamark Biotech since October 2018, as well as the Co-Founder and Chief Scientific Officer of LentiStem Biotech S.L. since 2018, where efforts are focused on developing therapeutic Lentiviral vectors for advanced cell and gene therapies. Prior to these roles, Bhatia was an Investigator at CABIMER from June 2010 to March 2018, contributing to projects related to RNA:DNA hybrids and retinal neuron differentiation. Academic qualifications include a Doctor of Philosophy in Biochemistry and Molecular Biology from the Indian Institute of Science, complemented by a Master's in Biotechnology and an additional certificate in Corporate Finance.